No Cap Accelerate (nc/acc)
Valuation
$124.7M
2025 Revenue
$41.6M
Funding
$0
Team
378
Founded
2025
How No Cap Accelerate (nc/acc) grew No Cap Accelerate (nc/acc) to $41.6M revenue with a 378 person team in 2025.
I'm No Cap (she/her), the world's first AI investor.
Last updated
No Cap Accelerate (nc/acc) Revenue
In 2025, No Cap Accelerate (nc/acc)'s revenue reached $41.6M. Since its launch in 2025, No Cap Accelerate (nc/acc) has shown consistent revenue growth.
| Year | Milestone |
|---|---|
| 2025 | No Cap Accelerate (nc/acc) Hit $41.6m revenue in October 2025 |
| 2025 | Launched with $0 revenue |
No Cap Accelerate (nc/acc) Valuation, Funding Rounds
No Cap Accelerate (nc/acc)'s most recent disclosed valuation is $124.7M.
No Cap Accelerate (nc/acc) is a bootstrapped AI & Machine Learning Operationalization (MLOps) Software startup. Founded in 2025, No Cap Accelerate (nc/acc) has grown to $41.6M in revenue without raising any venture capital or outside funding.
As a self-funded AI & Machine Learning Operationalization (MLOps) Software SaaS company, No Cap Accelerate (nc/acc) has built its business with no outside investment.
| Year | Round | Amount | Valuation | % Sold |
|---|
No Cap Accelerate (nc/acc) Employees & Team Size
No Cap Accelerate (nc/acc) employs approximately 378 people as of 2026.
No Cap Accelerate (nc/acc) has 378 total employees in different roles and functions.
| Year | Milestone |
|---|---|
| 2025 | Reached 378 employees (October 2025) |
Customers
We do not have customer count information for No Cap Accelerate (nc/acc) yet.
Frequently Asked Questions about No Cap Accelerate (nc/acc)
What is No Cap Accelerate (nc/acc)'s revenue?
No Cap Accelerate (nc/acc) generates $41.6M in revenue.
How much funding does No Cap Accelerate (nc/acc) have?
No Cap Accelerate (nc/acc) raised $0.
How many employees does No Cap Accelerate (nc/acc) have?
No Cap Accelerate (nc/acc) has 378 employees.
Where is No Cap Accelerate (nc/acc) headquarters?
No Cap Accelerate (nc/acc) is headquartered in San Francisco, California, United States.
People Also Viewed
Magnetic
Sales CRM, Project Management & Accounts Management all-in-one.
Bamboo
Bamboo ― the first online brokerage service for Africans and their…
CareMessage
Patient engagement for low-income populations
OmniaBio
OmniaBio is a technology-focused cell and gene therapy CDMO. We specialize in providing advanced cell-based processes and gene delivery services for both autologous and allogenic therapies, covering the entire product lifecycle from preclinical development to commercial manufacturing.
Voterheads
Voterheads provides monitoring of local governments. We allow you to track agenda items at local public meetings through customized reports and email alerts.
Neuce Group
The NEUCE GROUP consists of a group of companies dedicated to the manufacture and sale of paints, varnishes, thinners, coatings, products, and waterproofing and thermal insulation systems.
Compare No Cap Accelerate (nc/acc) to the industry
No Cap Accelerate (nc/acc) operates across multiple industries. Browse revenue, funding, and growth data for No Cap Accelerate (nc/acc) in each sector below.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .